Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Organoid Technology

The organoid technology is a fast-emerging pre-clinical model system. Organoids closely resemble the organ they were derived from and can be obtained with high efficiency from patient-derived healthy and diseased tissue, which opens opportunities for the development of individualized therapies. Embedded within the Drost group, the organoid facility supports organoid-based projects by facilitating quality-tested conditioned media, growth factors and know-how.
What we offer:
  • R-spondin-conditioned medium
  • Noggin-conditioned medium
  • BME